HKSE · 2877.HK
China Shineway Pharmaceutical Group Limited
HK$7.54+HK$0.26 (+3.5%)
China Shineway Pharmaceutical Group Limited’s quoted price sits in the lower half of its reported 52-week range, 28.03% below the high.
Loading market information…
HKSE · 0570.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:41 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
China Traditional Chinese Medicine Holdings Co. Limited’s quoted price sits in the lower half of its reported 52-week range, 51.04% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
China Traditional Chinese Medicine Holdings Co. Limited’s forward annual dividend is HK$0.05 per share, paid annual. The forward yield is 4.41% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
China Traditional Chinese Medicine Holdings Co. Limited’s next earnings report is currently expected on Mar 19, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow China Traditional Chinese Medicine Holdings Co. Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
China Traditional Chinese Medicine Holdings Co. Limited functions as an investment holding company, primarily focusing on the research, development, and sale of traditional Chinese medicine and other pharmaceutical goods across the People's Republic of China. The company's product range includes medicinal granules, finished pharmaceutical preparations, pre-portioned decoction materials, and various healthcare products. Furthermore, its operations extend to the cultivation and management of Chinese medicinal herbs, the manufacturing of traditional Chinese medicines, and the trading of pharmaceutical products. It also delivers marketing, advertising, and consulting services related to TCM, and operates retail outlets for pharmaceuticals and decoction products. Property leasing services represent another facet of its business. The company distributes its products to healthcare facilities and retail pharmacies. Established in 1573 and headquartered in Wan Chai, Hong Kong, the firm was formerly known as China Traditional Chinese Medicine Co. Limited before adopting its current name in July 2016.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:57 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2022 | Mar 24, 2023 | HK$0.08 | HK$9.50B-57.52% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$7.54+HK$0.26 (+3.5%)
China Shineway Pharmaceutical Group Limited’s quoted price sits in the lower half of its reported 52-week range, 28.03% below the high.
HK$5.65+HK$0.11 (+1.99%)
Beijing Tong Ren Tang Chinese Medicine Company Limited’s quoted price sits in the lower half of its reported 52-week range, 40.58% below the high.
HK$2.98+HK$0.07 (+2.41%)
Tong Ren Tang Technologies Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.8% below the high.
HK$2.65-HK$0.05 (-1.85%)
Jilin Province Huinan Changlong Bio-pharmacy Company Limited’s quoted price sits in the upper half of its reported 52-week range, 11.67% below the high.
HK$1.41-HK$0.03 (-2.08%)
Beijing Tong Ren Tang Healthcare Investment Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 70.56% below the high.
HK$0.63-HK$0.02 (-2.34%)
Zhongzhi Pharmaceutical Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 36.22% below the high.
HK$0.36+HK$0.02 (+5.88%)
Wai Yuen Tong Medicine Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 26.53% below the high.
HK$0.34HK$0.00 (0.0%)
Modern Chinese Medicine Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 89.57% below the high.
